Uncategorized
Demystifying Salesforce: Insights From 18 Analyst Reviews
Latest Ratings for CRM Date Firm Action From To Mar 2022 Wedbush Maintains Outperform Mar 2022 Canaccord Genuity Maintains Buy Mar 2022 Raymond James Maintains Strong Buy View More Analyst Ratings for CRM View the Latest Analyst Ratings read more
Forecasting The Future: 6 Analyst Projections For Chemed
Latest Ratings for CHE Date Firm Action From To Mar 2022 RBC Capital Maintains Outperform Jul 2021 RBC Capital Maintains Outperform Feb 2021 Oppenheimer Maintains Outperform View More Analyst Ratings for CHE View the Latest Analyst Ratings read more
AT&T Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)
Latest Ratings for T Date Firm Action From To Mar 2022 TD Securities Downgrades Buy Hold Feb 2022 JP Morgan Upgrades Neutral Overweight Feb 2022 Raymond James Maintains Outperform View More Analyst Ratings for T View the Latest Analyst Ratings read more
What 7 Analyst Ratings Have To Say About Performance Food Gr
Latest Ratings for PFGC Date Firm Action From To Mar 2022 CL King Initiates Coverage On Buy Feb 2022 Morgan Stanley Maintains Overweight Feb 2022 Truist Securities Initiates Coverage On Buy View More Analyst Ratings for PFGC View the Latest Analyst Ratings read more
What Analysts Are Saying About Ligand Pharmaceuticals Stock
Latest Ratings for LGND Date Firm Action From To Feb 2022 Benchmark Maintains Buy Feb 2022 Barclays Maintains Overweight Sep 2021 Barclays Maintains Overweight View More Analyst Ratings for LGND View the Latest Analyst Ratings read more
